LOUISVILLE, Colo., September 4, 2013 – GlobeImmune, Inc., announced today that it has been awarded a $4 million Research Project Grant (R01) by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to … Continue reading
GlobeImmune Awarded $4 Million NIH Grant to Develop Tarmogens for the Treatment of Tuberculosis
September 04, 2013